Fifteen normal volunteers were administered placebo, 0.250, 0.375 and
0.500 mg of triazolam in a double-blind cross-over design. Triazolam i
nduced robust dose-dependent impairments in explicit memory of informa
tion presented after drug administration. Subjects were unaware of the
ir memory deficit (an impairment in meta-cognition). In contrast, memo
ry for information presented prior to the administration of triazolam
was facilitated following the administration of low doses of triazolam
. Implicit memory and access to knowledge memory was unaltered by this
benzodiazepine, An analysis of these results controlling for concurre
nt sedation as measured subjectively, through the use of self rating s
cales and objectively, based upon psychomotor performance, demonstrate
d that the amnestic effects of triazolam are largely independent of se
dative effects. The pattern of memory changes induced by benzodiazepin
es, such as triazolam, is similar to the memory inpairment expressed i
n amnestic patients but unlike the pattern of impaired memory evident
in dementia such as Alzheimer's disease.